SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to discussions around a potential short squeeze and recent volatility, sparked by news of their expansion into menopause treatments. The stock's price action is seeing a lot of back and forth between bulls and bears. Some traders point to the potential for further gains, while others cite concerns about valuation and management actions.

Aventus Network

Aventus Network ($AVT) is trending, with community members expressing excitement about its potential, particularly its Aventus Cloud service. Discussion includes its interoperability with Polkadot and Ethereum, as well as its listing on Coinbase. Some users believe $AVT is undervalued and poised for significant growth.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to levels not seen in over a decade, driven by a potential short squeeze and global demand for bullion. Community discussions revolve around whether the rally is sustainable, with some citing supply shortages and a potential for further gains, while others warn of a possible pullback. The broader context includes concerns about the dollar and traditional safe haven assets.

Digital Turbine, Inc. is a mobile growth platform that offers solutions for advertisers, publishers, carriers, and device original equipment manufacturers (OEMs). The firm operates through the On Device Solutions (ODS) and App Growth Platform (AGP) segments. The ODS segment generates revenue from the delivery of mobile application media or content to end users with solutions for all participants in the mobile application ecosystem that want to connect with end users and consumers who hold the device. This includes mobile carriers and device OEMs that participate in the app economy, app publishers and developers, and brands and advertising agencies. The AGP segment provides platforms that allow mobile app publishers and developers to monetize their monthly active users via display, native, and video advertising. The company was founded on November 6, 1998 and is headquartered in Austin, TX.

Digital Turbine Inc

Digital Turbine ($APPS) is trending as investors discuss its potential in the evolving app store landscape, particularly following recent rulings impacting Google's Play Store policies. Community members are speculating on how the company might capitalize on these changes and forge new partnerships, with some drawing comparisons to the AI-driven growth of companies like Applovin. Bullish sentiment is building amidst discussions of potential short squeezes and a multi-year uptrend.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending following news of FDA fast track designation, sparking significant community discussion and a surge in price and volume. Traders are pointing to technical indicators and potential short squeezes, while analysts have increased price targets. The community is actively debating potential breakout levels and the stock's overall potential in the biotherapeutics space.

Aptera Motors Corp. is an automotive technology company focused on the development, production, and distribution of energy-efficient, solar-powered, battery-electric vehicles. Its flagship product, the Aptera, is a three-wheeled, two-seat solar vehicle designed to reduce reliance on traditional charging by utilizing integrated solar panels. The company was founded by Steve Fambro and Chris Anthony and is headquartered in San Diego, CA.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

Aptera Motors ($SEV) is trending due to high volatility following its direct listing, with community members actively discussing trading halts and potential market manipulation.  While some investors express excitement about the company's solar EV technology and pre-order demand, others voice concerns about production timelines and the vehicle's design.  The stock's extreme price fluctuations have fueled speculation about short squeezes and long-term potential within the EV sector.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is surging, fueled by safe-haven demand amid economic uncertainty and global dissatisfaction. The community is debating whether this rally signals a blow-off top or a continuation of the upward trend, with some expressing concerns about overbought conditions and potential pullbacks. Discussions also revolve around the interplay between gold, the dollar, and potential shifts in global economic power.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is trending due to investor reactions to its AI strategy and cloud infrastructure spending, particularly after the company's AI World event. While some analysts are optimistic about long-term revenue potential, the community is concerned about near-term profitability, rising debt, and heavy capital expenditure, leading to a sell-off despite positive AI cloud deals.

Gitlab, Inc. provides code hosting and collaboration platform services. It offers continuous integration, source code management, out-of-the-box pipelines, agile development, and value stream management. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in Dover, DE.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

GitLab ($GTLB) is trending amid takeover speculation, with Datadog ($DDOG) and Google ($GOOGL) mentioned as potential acquirers and a possible bidding war. The community is weighing the potential deal price, with some focusing on a $50 breakout level while others suggest a price above $60 per share is more realistic. Despite the takeover buzz, some traders dismiss the rumors and express concern about the stock's performance.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CVM is trending as investors await a potential decision from the Saudi Food and Drug Authority (SFDA) regarding Cel-Sci's application for Breakthrough Medicine Designation for Multikine. Community members are debating the timeline for the SFDA's decision and its potential impact, with some expressing skepticism towards the CEO's statements, while others highlight the partnership with Dallah Pharma and potential for commercialization in Saudi Arabia.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Compared to Estimates, RXO (RXO) Q2 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for RXO (RXO) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

RXO (RXO) Q2 Earnings Top Estimates

RXO (RXO) delivered earnings and revenue surprises of +100.00% and -2.21%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Schneider National (SNDR) Q2 Earnings Match Estimates

Schneider National (SNDR) delivered earnings and revenue surprises of 0.00% and -0.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate RXO (RXO) to Report a Decline in Earnings: What to Look Out for

RXO (RXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RXO (RXO) Surges 6.3%: Is This an Indication of Further Gains?

RXO (RXO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

RXO Releases the Q1 Curve Freight Market Forecast

Today, RXO (NYSE: RXO), a leader in asset-light transportation solutions, released its proprietary Q1 2025 Curve Truckload Market Forecast. The long-trusted quarterly forecast continues under RXO...

RXO Releases New Original Research on Supply Chain KPIs

RXO (NYSE: RXO) a leader in asset-light transportation solutions, released new original research today that reveals how 1,000 industry experts are setting standards for key performance indicators...

RXO Reports Fourth-Quarter Results

RXO (NYSE: RXO) today announced its financial results for the fourth quarter of 2024. Drew Wilkerson, chief executive officer of RXO, said, The integration of Coyote Logistics remains ahead of...

Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference

Smaller public U.S. companies have underperformed larger company stocks for the better part of the past decade but the investment professionals at Emerald Asset Management are seeing the emerging...

RXO Announces Participation at Upcoming Investor Conferences

RXO (NYSE: RXO) today announced that Chief Executive Officer Drew Wilkerson and Chief Strategy Officer Jared Weisfeld will participate in the following investor conferences: Event: Citis 2025 Global...

RXO, Inc. engages in providing asset-light transportation solutions. It also offers managed transportation, freight forwarding, and last mile delivery. The company was founded on May 5, 2022 and is headquartered in Charlotte, NC.

RXO Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$17.22
Prev Close	$17.84
Open	$17.41
Dividend Yield	0.00%
50-Day Moving Average	$16.16
Beta	1.42
Avg. Volume	2.22M
PE Ratio	-8.21

52-Week High	$31.98
52-Week Low	$12.19
Market Capitalization	$2.93B
EPS (Annual)	-$2.17
Price to Book	1.84
Revenue Per Employee	$460,852.83
Enterprise Value/EBITDA	N/A

RXO
RXO INC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RXO News

RXORXO INC